You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
Planning
2019 Novel Coronavirus Stakeholder
Aligning Health Care Industry Cybersecurity Approaches
ASPR Playbooks
At-Risk, Behavioral Health...(ABC)
Critical Infrastructure Protection
Cybersecurity TF
EPAP
Gaps in Contraception Access and Zika
HPP
Hurricane Sandy Research Grants
Incident Response Framework
Last Mile
Legal Authority and Other Guidance
Medical Planning and Response Manual for a Nuclear Detonation Incident: A Practical Guide
Medical Surge Capacity Capability
National Influenza Vaccine Modernization Strategy 2020-2030
National Plus
Partnership for Disaster Health Response Cooperative Agreement
Postal Model for Medical Countermeasures Delivery and Distribution
Public Health and Healthcare Systems Evaluation
International Preparedness and Response
Global Health Security Initiative (GHSI)
International CONOPS
International Health Regulations
Security and Prosperity Partnership
Southern Caucasus Collaboration and Partnership in Countering Biological Threats
Outbreak Response and Bioterrorism Investigation Trilateral Forum
Countering Biological Threats
North American Plan for Animal and Pandemic Influenza
U.S. Health Security National Action Plan: Strengthening Implementation of the International Health Regulations
Medical Countermeasures
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
PHEMCE
PHEMCE Review 2010
BARDA Funds Medical Countermeasure Innovation
HHS Centers for Innovation in Advanced Development and Manufacturing
BARDA evaluates burn dressing for radiation, sulfur mustard burns
BARDA funds study of therapy for thermal burns
HHS explores new emergency response use for approved steroid
HHS funds development of freeze-dried platelets for disaster response
BARDA funds development of device to aid burn patients in disasters
New blood test would provide fast results for medical care after anthrax attack
BARDA boosts global ability to respond to pandemics
New diagnostic test to detect the presence of an influenza virus and identify its genetic profile
New device could reduce time needed to test for bacteria, such as anthrax
Mass decontamination research provides new scientific evidence for responders, hospitals to decontaminate chemical terrorism, accident survivors
HHS pursues fast, easy test for anthrax and multi-drug resistant anthrax infections
HHS pursues development of panels of blood-based biomarkers for several biothreat pathogens
BARDA funds advanced development of drug to treat injuries from exposure to cyanide
BARDA supports development of antitoxin administered as a traditional shot
BARDA funds development of drugs to treat injuries from chemical bioterrorism
Public Health and Medical Services Support
Emergency Preparedness
Emergency Support Function
Legal Authority of the Secretary
Medical Assistance
Medical Response
Medical Surge Capacity Capability
EMS and First Responders
Responders Clinicians & Practitioners
National Disaster Medical System
Regional Emergency Coordinators
Secretary's Operations Center
Guidance for Protecting Responders’ Health During the First Week Following A Wide-Area Aerosol Anthrax Attack
Frequently Asked Questions
Patient Decontamination Following Chemical Incidents
Ebola Preparedness for the U.S. Healthcare System
Response to Comments for Patient Decontamination in a Mass Chemical Exposure Incident: National Planning Guidance for Communities
National Survey of Health Insurance Plan Emergency Preparedness Report
Legal Authorities
Boards and Committees
Guidance
Pandemic and All Hazards Preparedness Act (PAHPA)
Public Health Resources
Public Readiness and Emergency Preparedness (PREP) Act
Public Health Emergency Declaration
Public Health Emergency Declaration Q&As
1135 Waivers
COVID-19: Coronavirus Disease 2019
ASPR Redirect Page
Redirect to ASPR COVID-19 News
National Biodefense Strategy
2019 Biodefense Public Report
Goals and Objectives
Interagency Coordination
Resources
Frequently Asked Questions: National Biodefense Strategy
Biodefense Summit
About the Biodefense Summit
Call for Public Comments: National Biodefense Strategy Implementation
Biodefense Summit Transcripts
Welcome Remarks
Opening Remarks
Importance of the Biodefense Summit
Evolution of U.S. Biodefense Policy
Goal 1: Enabling Risk Awareness to Inform Decision Making across the Biodefense Enterprise
Goal 1: Discussion Questions and Answers
Goal 2: Ensure Biodefense Enterprise Capabilities to Prevent Bioincidents
Site Contents
Skip over global navigation links
Office of the Assistant Secretary for Preparedness and Response
Preparedness
Emergency
About ASPR
Public Health Emergency - Leading a Nation Prepared
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
PHE Home
>
Preparedness
Preparedness News Releases
Main Content
URL
December 15, 2020: HHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patients
December 11, 2020: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
December 2, 2020: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
November 23, 2020: HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
October 30, 2020: Trump Administration Producing Supply Kits to Safely Administer COVID-19 Vaccines to Americans
October 28, 2020: HHS, DOD Collaborate on Plans to Purchase of Lilly Investigational Therapeutic to Treat COVID-19
October 23, 2020: HHS Delivers 125 Million Masks to Support Safe School Reopening
October 13, 2020: Trump Administration Expands Manufacturing Capacity with Cytiva for Components of COVID-19 Vaccines
October 9, 2020: Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19
October 6, 2020: HHS funds development of needle-free vaccine administration technology
October 1, 2020: Veklury (remdesivir) Now Available Directly from Distributor following Trump Administration’s Successful Allocations to States and U.S. Territories
September 30, 2020: HHS selects third pilot site to demonstrate better approach to disaster medical care
September 30, 2020: Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS
October 30, 2020: Trump Administration Producing Supply Kits to Safely Administer COVID-19 Vaccines to Americans
September 16, 2020: Review of ASPR’s Coronavirus Response Efforts: Statement by HHS Assistant Secretary for Preparedness and Response Robert Kadlec
September 16, 2020: HHS Secretary Azar Declares Public Health Emergency in Oregon Due to Wildfires
August 28, 2020: COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19
August 26, 2020: HHS Secretary Azar declares public health emergencies in Louisiana and Texas due to Hurricane Laura
August 26, 2020: HHS Secretary Azar declares Public Health Emergency in California due to wildfires
August 25, 2020: Trump Administration to Release 1.5 Million N95 Respirators from the Strategic National Stockpile for Distribution to Nursing Homes
August 11, 2020: Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
August 5, 2020: HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses
August 5, 2020: Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance
July 31, 2020: HHS, DOD Partner With Sanofi and GSK on Commercial-Scale Manufacturing Demonstration Project to Produce Millions of COVID-19 Investigational Vaccine Doses
July 9, 2020: BARDA and JPEO-CBRND establish partnership with Retractable Technologies, Inc. to expand the capacity to manufacture needles and syringes in the US
July 9, 2020: BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes
July 7, 2020: HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects
July 7, 2020: HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment
June 29, 2020: Trump Administration Secures New Supplies of Remdesivir for the United States
May 21, 2020: Trump Administration’s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October
May 19, 2020: HHS, Industry Partners Expand U.S.-Based Pharmaceutical Manufacturing for COVID-19 Response
May 9, 2020: HHS announces shipments of donated remdesivir for hospitalized patients with COVID-19
April 16, 2020: HHS Announces Ventilator Contract with GE Under Defense Production Act
April 13, 2020: HHS facilitates development of immunotherapies for COVID-19 patients
April 8, 2020: HHS to Provide Millions of TYVEK Protective Suits for U.S. Healthcare Workers
April 8, 2020: HHS Announces Ventilator Contract with GM under Defense Production Act
April 8, 2020: HHS Announces Ventilator Contract with Philips under Defense Production Act
March 30, 2020: HHS Accelerates Clinical Trials, Prepares for Manufacturing of COVID-19 Vaccines
March 29, 2020: HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients
March 24, 2020: HHS Provides $100 Million to Help U.S. Healthcare Systems Prepare For COVID-19 Patients
March 22, 2020: HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections
March 21, 2020: HHS Funds Phase 2/3 Clinical Trial for Potential Treatment for COVID-19
March 18: HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections
March 13, 2020: HHS funds development of COVID-19 diagnostic tests
March 9, 2020: HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test
March 6, 2020: HHS Solicits Proposals for Development of Medical Products for Novel Coronavirus
March 4, 2020: HHS to Procure N95 Respirators to Support Healthcare Workers in COVID-19 Outbreaks
February 22, 2020: BARDA Leverages Strong Public-Private Partnerships to Spur a Rapid Response to the Novel Coronavirus Outbreak
February 18, 2020: HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine
February 18, 2020: HHS, Janssen Collaborate To Develop Coronavirus Therapeutics
1 - 50
Compliance Details
javascript:commonShowModalDialog('{SiteUrl}'+ '/_layouts/15/itemexpiration.aspx' +'?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/hold.aspx' +'?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/Reporting.aspx' +'?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/expirationconfig.aspx' +'?ID={ItemId}&List={ListId}'); return false;}}, null);
0x0
0x1
ContentType
0x01
898
Document Set Version History
/_layouts/15/images/versions.gif?rev=23
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}'+ '/_layouts/15/DocSetVersions.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
/_layouts/15/images/sendOtherLoc.gif?rev=23
javascript:GoToPage('{SiteUrl}' + '/_layouts/15/docsetsend.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350
Right Box1 Content
Right Box2 Content
Stay Up To Date with PHE.gov
Newsroom
Watch, Listen, Subscribe
This page last reviewed: August 05, 2020
